Tate art galleries will not accept donations from Sacklers

pharmafile | March 22, 2019 | News story | Medical Communications OxyContin, Purdue Pharma, Sacklers, Tate, art galleries, opioid crisis 

The Tate network of art galleries has said it will no longer accept gifts from the notorious Sackler family, the billionaire controllers of OxyContin drugmaker Purdue Pharma.

The decision comes after the National Portrait Gallery turned down a £1 million gift from the Sackler’s who are accused of playing a fundamental role in the opioid epidemic. The backlash follows protests from photographer Nan Goldin.

Goldin recently led anti-Sackler demonstrations in the Guggenheim and Metropolitan Museum of Art in New York. However the artist had not discussed boycotting the Sacklers with the Tate group.

Goldin had previously suffered from addiction herself having been dependent on OxyContin in 2015 after being prescribed the painkiller for a painful wrist. In discussing the Tate group’s decision, Goldin said “We are thrilled.”

The Tate group of galleries includes four galleries: Tate Liverpool, Tate St Ives, and the Tate Modern and Tate Britain in London.

“In the present circumstances we do not think it right to seek or accept further donations from the Sacklers,” The Tate group said.

Louis Goss

Related Content

shutterstock_512649

Johnson & Johnson to contribute a further $1 billion to US opioid settlement

Johnson & Johnson will pay another $1 billion to settle lawsuits alleging it fuelled the …

Photo by Psiĥedelisto

Democratic Senators urge judge to reject Purdue Pharma’s proposal to pay CEO a bonus

Democratic US Senators are urging Judge Robert D. Drain to reject Purdue Pharma’s proposal to …

800px-jnjioffice

New York files $2 billion lawsuit against J&J for downplaying risks of opioids in its marketing

New York State is suing Johnson & Johnson in a lawsuit seeking $2 billion in …

Latest content